Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-056781

Chief Executive Officer sold 4,400 shares at an average $15.02 ($66,066)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-10-11 Sale : show line 1 in the form −2,200 $15.25 $33,550 430,778 I
2017-10-12 Sale : show line 2 in the form −2,200 $14.78 $32,516 428,578 I
Open-market sales · 4,400 sh · avg $15.02 · $66,066
Loading xslF345X03/doc4.xml…